These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 2930708)
1. Predictors of hormone response for patients with ER-unknown breast tumours. Hug V; Thames H; Bentzen S Br J Cancer; 1989 Mar; 59(3):421-5. PubMed ID: 2930708 [TBL] [Abstract][Full Text] [Related]
2. [Expression of oestrogen receptor-beta in invasive breast tumours]. Péter I; Számel I; Péley G Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898 [TBL] [Abstract][Full Text] [Related]
3. [Hormone-dependency of human breast cancer in in vitro clonogenic assay]. Nomura Y; Tashiro H; Takaekoh F; Hisamatsu K Gan No Rinsho; 1987 Feb; 33(2):153-8. PubMed ID: 3560449 [TBL] [Abstract][Full Text] [Related]
4. Proteinase-like peptidase activities and oestrogen receptor levels in breast cancer tissue. Vasishta A; Baker PR; Preece PE; Wood RA; Cuschieri A J Cancer Res Clin Oncol; 1989; 115(1):89-92. PubMed ID: 2921276 [TBL] [Abstract][Full Text] [Related]
5. Oestrogen receptor status of breast cancers from related patients. Crawford DJ; McGown A; Cowan S; Leake RE; Smith DC Eur J Surg Oncol; 1986 Sep; 12(3):257-9. PubMed ID: 3758364 [TBL] [Abstract][Full Text] [Related]
6. Hormone receptors and Japanese breast cancer. Matsumoto K; Kitamura Y; Sugano H Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994 [TBL] [Abstract][Full Text] [Related]
7. Oestrogen-receptor status in management of breast cancer in UK. Mander BJ; Heal K; Porushotham AD; Wishart GC Lancet; 1998 Jul; 352(9121):36-7. PubMed ID: 9800752 [No Abstract] [Full Text] [Related]
8. Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer? Barnes DM; Skinner LG; Ribeiro GG Br J Cancer; 1979 Dec; 40(6):862-5. PubMed ID: 230853 [TBL] [Abstract][Full Text] [Related]
9. Characterization and biological relevance of a 29-kDa, oestrogen receptor-related protein. King RJ; Finley JR; Coffer AI; Millis RR; Rubens RD J Steroid Biochem; 1987; 27(1-3):471-5. PubMed ID: 3695491 [TBL] [Abstract][Full Text] [Related]
10. Steroid receptors in breast cancer. Desombre ER Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047 [TBL] [Abstract][Full Text] [Related]
11. Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay. Saccani Jotti G; Johnston SR; Salter J; Detre S; Dowsett M J Clin Pathol; 1994 Oct; 47(10):900-5. PubMed ID: 7962603 [TBL] [Abstract][Full Text] [Related]
12. Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Henry JA; Nicholson S; Hennessy C; Lennard TW; May FE; Westley BR Br J Cancer; 1990 Jan; 61(1):32-8. PubMed ID: 2153395 [TBL] [Abstract][Full Text] [Related]
13. Changes in multiple or sequential estrogen receptor determinations in breast cancer. Allegra JC; Barlock A; Huff KK; Lippman ME Cancer; 1980 Feb; 45(4):792-4. PubMed ID: 7357496 [TBL] [Abstract][Full Text] [Related]
14. Oestrogen and progesterone receptor distribution in the cancerous breast. Panahy C; Puddefoot JR; Anderson E; Vinson GP; Berry CL; Turner MJ; Brown CL; Goode AW Br J Cancer; 1987 Apr; 55(4):459-62. PubMed ID: 3580270 [TBL] [Abstract][Full Text] [Related]
15. Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapy. McClelland RA; Manning DL; Gee JM; Willsher P; Robertson JF; Ellis IO; Blamey RW; Nicholson RI Br J Cancer; 1998 May; 77(10):1653-6. PubMed ID: 9635843 [TBL] [Abstract][Full Text] [Related]
16. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer. McClelland RA; Finlay P; Walker KJ; Nicholson D; Robertson JF; Blamey RW; Nicholson RI Cancer Res; 1990 Jun; 50(12):3545-50. PubMed ID: 2187598 [TBL] [Abstract][Full Text] [Related]
17. Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy. Alkner S; Ehinger A; Bendahl PO; Rydén L; Fernö M Eur J Cancer; 2015 Nov; 51(16):2304-13. PubMed ID: 26243193 [TBL] [Abstract][Full Text] [Related]
18. [Use of protamine sulfate in a method for determining the hormonal sensitivity of breast cancer]. Degtiar' VG; Denisov LE; Iarygin LM; Khotchenkova NV Vopr Onkol; 1985; 31(1):51-5. PubMed ID: 3976194 [TBL] [Abstract][Full Text] [Related]
19. Better estrogen receptor assay in the offing. González ER JAMA; 1981 Mar; 245(9):905-6. PubMed ID: 7463685 [No Abstract] [Full Text] [Related]
20. Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer. Robertson JF; Bates K; Pearson D; Blamey RW; Nicholson RI Br J Cancer; 1992 May; 65(5):727-30. PubMed ID: 1534019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]